Beam Therapeutics Stock (NASDAQ:BEAM): Investing in Cutting-Edge Gene Editing

TipRanks04:37

Popular Crypto Trader Shares 2024 Predictions For These Three Altcoins

Popular pseudonymous crypto analyst Altcoin Sherpa on Friday shared his insights on three altcoins: Beam (CRYPTO: BEAM), Arbitrum (CRYPTO: ARB), and Render (CRYPTO: RNDR). BEAM: A Bullish Bet On Crypt

BenzingaApr 13 01:55

Beam Therapeutics (NASDAQ:BEAM) Is In A Good Position To Deliver On Growth Plans

Yahoo FinanceApr 11 19:14

Beam Therapeutics Insider Sold Shares Worth $734,805, According to a Recent SEC Filing

Amy Simon, Chief Medical Officer, on April 01, 2024, sold 23,687 shares in Beam Therapeutics (BEAM) for $734,805. Following the Form 4 filing with the SEC, Simon has control over a total of 70,060 sha

MT NewswiresApr 4 22:15

Beam Therapeutics: A Buy Rating Amidst Gene Editing Industry Developments

TipRanksApr 3 07:25

Form 144 | Beam Therapeutics(BEAM.US) Officer Proposes to Sell 504.85K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 2, $Beam Therapeutics(BEAM.US)$ Officer AMY SIMON intends to sell 16,530 shares of its common stock on Apr 2, with a total market value of approximately $504.85K. AMY SIM

Futu NewsApr 3 04:28